Topiramate Tablet, Film Coated
Product Images NDC 72789-471

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 72789-471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789471 Label (72789471)

72789471 Label (72789471)
Topiramate USP 25 mg film-coated tablets label for a 90-tablet bottle by PD-Rx Pharmaceuticals, Inc. The label includes NDC 72789-471-90, lot A25C02, and expiration date 01/2026. It features usage instruction blanks, safety warning to keep out of reach of children, and manufacturer information including address in Oklahoma City, OK. A QR code is present along with barcode and packaging details.*
FDA Label Image

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)
A cumulative incidence curve graph showing cumulative rates for time to first seizure over a period of 500 days. Two groups are compared: one receiving Topiramate 50 mg/day (N=234) and another receiving Topiramate 400 mg/day (N=236). The y-axis shows cumulative rates, and the x-axis shows time in days. A statistical significance p-value of 0.0002 is indicated on the graph.*
FDA Label Image

Figure 2 (Topiramate Fig2)

Figure 2 (Topiramate Fig2)
A bar chart comparing the change from baseline in average monthly migraine period rate during the double-blind phase across different doses of Topiramate (50 mg/day, 100 mg/day, 200 mg/day) and placebo groups from two studies (Study 11 and Study 12). The chart shows decreasing migraine rates with increasing Topiramate dose, with statistical significance indicated for 100 mg/day and 200 mg/day doses.*
FDA Label Image

Chemical Structure (Topiramate Str)

Chemical Structure (Topiramate Str)
Chemical structure of Topiramate, showing its molecular arrangement with various functional groups including methyl, sulfate, and oxygen-containing rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.